我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

LOX-1在动脉粥样硬化中的作用研究新进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2018年第2期
页码:
212-217
栏目:
综述
出版日期:
2018-02-15

文章信息/Info

Title:
Effect of LOX-1 on development of atherosclerosis
作者:
郑 旭1; 张梦诃2; 邓 姣3; 董海龙3
第四军医大学：1.学员旅，2.护理系，3.西京医院麻醉科，陕西 西安 710032)
Author(s):
ZHENG Xu1;  ZHENG Meng-ke2;  DENG Jiao3;  DONG Hai-long3
(1.Cadet Brigade, 2.Nursing Department, 3.Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi, China)
关键词:
瘦素样氧化型低密度脂蛋白受体1; 氧化型低密度脂蛋白; 动脉粥样硬化
Keywords:
Lectin-like oxidized LDL receptor-1;  oxidized low density lipoprotein;  atheroscleros
分类号:
R543.5
DOI:
-
文献标识码:
A
摘要:
动脉粥样硬化(AS)是一种血管慢性炎症性病变，其中内皮细胞功能异常、单核细胞的黏附和迁移、平滑肌细胞的凋亡、泡沫细胞的形成和血小板的活化是AS形成的关键环节，最终结果是形成大、中动脉内膜下的粥样硬化斑块，造成管腔狭窄，远端组织器官供血不足甚至栓塞。低密度脂蛋白（LDL） 氧化形成的氧化型LDL（ox-LDL）在AS发生、发展过程中起着重要作用。目前在与AS发生、发展相关的细胞（如血管内皮细胞、血管平滑肌细胞、单核细胞、巨噬细胞以及泡沫细胞）上已经发现和鉴定了多种oxLDL受体，其中瘦素样氧化型低密度脂蛋白受体(LOX)-1表达于血管内皮细胞、巨噬细胞、血小板上，是ox-LDL的主要受体［1］，在AS的发生、发展中起着重要作用，本文将着重阐述近年来LOX-1影响AS发生发展相关效应与机制的新进展。
Abstract:
Atherosclerosis (AS) is a chronic inflammation of blood vessels, in which endothelial cell dysfunction, monocyte adhesion and migration, apoptosis of smooth muscle cell, foam cell formation, and platelet activation are all critical parts of atherosclerosis. AS will result in large and medium artery atherosclerotic plaques under the intima. Ox-LDL, which results from oxidation of low density lipoprotein (LDL), is involved in the occurrence and development of atherosclerosis. Many ox-LDL receptors have been found and identified on cells related to development of AS, such as vascular endothelial cells, vascular smooth muscle cells, monocytes, macrophages and foam cells. Lectin-like oxidized LDL receptor-1 (LOX-1), the main receptor of ox-LDL, is expressed on vascular endothelial cells, macrophages and platelets, and it plays a significant role in the development and progress of atherosclerosis. In this review, there is a focus on the latest development of effects of LOX-1 on AS development and related underlying mechanisms.

参考文献/References

[1]Sawamura T,Kume N,Aoyama T,et al.An endothelial receptor for oxidized low-density lipoprotein[J].Nature,1997,386(6620):73-77.

[2]Yamada Y,Doi T,Hamakubo T,et al.Scavenger receptor family proteins:roles for atherosclerosis,host defence and disorders of the central nervous system[J].Cell Mol Life Sci,1998,54(7): 628-640.

[3]Mollace V,Gliozzi M,Musolino V,et al.Oxidized LDL attenuates protective autophagy and induces apoptotic cell death of endothelial cells:Role of oxidative stress and LOX-1 receptor expression[J].Int J Cardiol,2015,184:152-158.

[4]Parlato S,Romagnoli G,Spadaro F,et al.LOX-1 as a natural IFN-alpha-mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells[J].Blood,2010,115(8):1554-1563.

[5]Cominacini L,Fratta Pasini A,Garbin U,et al.The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells[J].J Am Coll Cardiol,2003,41(3):499-507.

[6]Akhmedov A,Rozenberg I,Paneni F,et al.Endothelial overexpression of LOX-1 increases plaque formation and promotes atherosclerosis in vivo[J].Eur Heart J,2014,35(40):2839-2848.

[7]Dunn S,Vohra RS,Murphy JE,et al.The lectin-like oxidized low-density-lipoprotein receptor:a pro-inflammatory factor in vascular disease[J].The Biochemical journal,2008,409(2):349-355.

[8]Chen B,Li J,Zhu H. AMP-activated protein kinase attenuates oxLDL uptake in macrophages through PP2A/NF-kappaB/LOX-1 pathway[J].Vascul Pharmacol,2015,85:1-10.

[9]Chui PC,Guan HP,Lehrke M,et al.PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1[J].J Clin Invest,2005,115(8):2244-2256.

[10]Inoue K,Arai Y,Kurihara H,et al.Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice[J].Circ Res,2005,97(2):176-184.

[11]Robbesyn F,Salvayre R,Negre-Salvayre A.Dual role of oxidized LDL on the NF-kappaB signaling pathway[J].Free Radic Res,2004,38(6):541-551.

[12]Dong Q,Xiang R,Zhang DY,et al.Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism[J].Braz J Med Biol Res,2013,46(9):765-770.

[13]Forstermann U,Sessa WC.Nitric oxide synthases:regulation and function[J].Eur Heart J,2012,33(7):829-837,837a-837d.

[14]Pernow J,Shemyakin A,Bohm F.New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus[J].Life Sci,2012,91(13-14):507-516.

[15]Li D,Mehta JL.Upregulation of endothelial receptor for oxidized LDL(LOX-1)by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells:evidence from use of antisense LOX-1 mRNA and chemical inhibitors[J].Arterioscler Thromb Vasc Biol,2000,20(4):1116-1122.

[16]Hong D,Bai YP,Gao HC,et al.Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway[J].Atherosclerosis,2014,235(2):310-317.

[17]Khaidakov M,Mitra S,Wang X,et al.Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells:a microarray study[J].PLoS One,2012,7(10):e47421.

[18]Chen JW,Zhou SB,Tan ZM.Aspirin and pravastatin reduce lectin-like oxidized low density lipoprotein receptor-1 expression,adhesion molecules and oxidative stress in human coronary artery endothelial cells[J].Chin Med J(Engl),2010,123(12):1553-1556.

[19]Sakamoto N,Ishibashi T,Sugimoto K,et al.Role of LOX-1 in monocyte adhesion-triggered redox,Akt/eNOS and Ca2+ signaling pathways in endothelial cells[J].J Cell Physiol,2009,220(3):706-715.

[20]Sun Y,Chen X.Ox-LDL-induced LOX-1 expression in vascular smooth muscle cells:role of reactive oxygen species[J].Fundam Clin Pharmacol,2011,25(5):572-579.

[21]Mehta JL,Sanada N,Hu CP,et al.Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet[J].Circ Res,2007,100(11):1634-1642.

[22]Yu J,Li Y,Li M,et al.Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro[J].Int J Exp Pathol,2010,91(1):24-33.

[23]Lin J,Xu Y,Zhao T,et al.Genistein suppresses smooth muscle cell-derived foam cell formation through tyrosine kinase pathway[J].Biochem Biophys Res Commun,2015,463(4):1297-1304.

[24]Stein S,Lohmann C,Schafer N,et al.SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis[J].Eur Heart J,2010,31(18):2301-2309.

[25]Crucet M,Wust SJ,Spielmann P,et al.Hypoxia enhances lipid uptake in macrophages:role of the scavenger receptors Lox1,SRA,and CD36[J].Atherosclerosis,2013,229(1):110-117.

[26]Yang Y,Lian YT,Huang SY,et al.GABA and topiramate inhibit the formation of human macrophage-derived foam cells by modulating cholesterol-metabolism-associated molecules[J].Cell Physiol Biochem,2014,33(4):1117-1129.

[27]Hao S Ji J,Zhao H,et al.Mitochondrion-Targeted Peptide SS-31 Inhibited Oxidized Low-Density Lipoproteins-Induced Foam Cell Formation through both ROS Scavenging and Inhibition of Cholesterol Influx in RAW264.7 Cells[J].Molecules,2015,20(12):21287-21297.

[28]Xia X,Li Y,Su Q,et al.Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice[J].Cell Biosci,2015,5:23.

[29]Seizer P,Schiemann S,Merz T,et al.CD36 and macrophage scavenger receptor a modulate foam cell formation via inhibition of lipid-laden platelet phagocytosis[J].Semin Thromb Hemost,2010,36(2):157-162.

[30]Chen M,Kakutani M,Naruko T,et al.Activation-dependent surface expression of LOX-1 in human platelets[J].Biochem Biophys Res Commun,2001,282(1):153-158.

[31]Zhu X,Li Z,Li C,et al.Ginkgo biloba extract and aspirin synergistically attenuate activated platelet-induced ROS production and LOX-1 expression in human coronary artery endothelial cells[J].Phytomedicine,2013,20(2):114-119.

[32]Marwali MR,Hu CP,Mohandas B,et al.Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling[J].J Pharmacol Exp Ther,2007,322(3):1324-1332.

[33]Lee JJ,Yang H,Yoo YM,et al.Morusinol extracted from Morus alba inhibits arterial thrombosis and modulates platelet activation for the treatment of cardiovascular disease[J].J Atheroscler Thromb,2012,19(6):516-522.

[34]Newby AC.Metalloproteinases and vulnerable atherosclerotic plaques[J].Trends Cardiovasc Med,2007,17(8):253-258.

[35]Finn AV,Nakano M,Narula J,et al.Concept of vulnerable/unstable plaque[J].Arterioscler Thromb Vasc Biol,2010,30(7):1282-1292.

[36]Clarke M,Bennett M.The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability[J].Am J Nephrol,2006,26(6):531-535.

[37]Hutcheson JD,Maldonado N,Aikawa E.Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability[J].Curr Opin Lipidol,2014,25(5): 327-332.

[38]Li L,Renier G.The oral anti-diabetic agent, gliclazide, inhibits oxidized LDL-mediated LOX-1 expression, metalloproteinase-9 secretion and apoptosis in human aortic endothelial cells[J].Atherosclerosis,2009,204(1):40-46.

[39]Saito A,Fujimura M,Inoue T,et al.Relationship between lectin-like oxidized low-density lipoprotein receptor 1 expression and preoperative echogenic findings of vulnerable carotid plaque[J].Acta Neurochir(Wien),2010,152(4):589-595.

[40]Sugimoto K,Ishibashi T,Sawamura T,et al.LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothelial cells[J].Cardiovasc Res,2009,84(1):127-136.

[41]Tsai KL,Chang YL,Huang PH,et al.Ginkgo biloba extract inhibits oxidized low-density lipoprotein(oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells[J].J Vasc Surg,2016,63(1):204-215.

[42]Hu C,Dandapat A,Sun L,et al.Regulation of TGFbeta1-mediated collagen formation by LOX-1:studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts[J].J Biol Chem,2008,283(16):10226-10231.

[43]Chang HC,Chen TG,Tai YT,et al.Resveratrol attenuates oxidized LDL-evoked Lox-1 signaling and consequently protects against apoptotic insults to cerebrovascular endothelial cells[J].J Cereb Blood Flow Metab,2011,31(3):842-854.

[44]Berbee JF,Wong MC,Wang Y,et al.Resveratrol protects against atherosclerosis,but does not add to the antiatherogenic effect of atorvastatin,in APOE*3-Leiden.CETP mice[J].J Nutr Biochem,2013,24(8):1423-1430.

[45]Ishino S,Mukai T,Kuge Y,et al.Targeting of lectinlike oxidized low-density lipoprotein receptor 1(LOX-1)with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque[J].J Nucl Med,2008,49(10):1677-1685.

[46]Clarke MC,Figg N,Maguire JJ,et al.Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis[J].Nat Med,2006,12(9):1075-1080.

[47]Kashiwakura Y,Watanabe M,Kusumi N,et al.Dynamin-2 regulates oxidized low-density lipoprotein-induced apoptosis of vascular smooth muscle cell[J].Circulation,2004,110(21):3329-3334.

[48]Rudijanto A.Calcium channel blocker(diltiazem)inhibits apoptosis of vascular smooth muscle cell exposed to high glucose concentration through lectin-like oxidized low density lipoprotein receptor-1(LOX-1)pathway[J].Acta Med Indones,2010,42(2):59-65.

[49]Mango R, Biocca S, del Vecchio F, et al. In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction[J].Circulation research,2005,97(2):152-158.

[50]Aydemir B,Baykara O,Cinemre FB,et al.LOX-1 gene variants and maternal levels of plasma oxidized LDL and malondialdehyde in patients with gestational diabetes mellitus[J].Arch Gynecol Obstet,2016,293(3):517-527.

[51]Jiang JX,Zhang SJ,Liu YN,et al.EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells[J].Eur J Pharmacol,2014,727:43-51.

[52]Murdocca M,Mango R,Pucci S,et al.The lectin-like oxidized LDL receptor-1:a new potential molecular target in colorectal cancer[J].Oncotarget,2016,7(12):14765-14780.

备注/Memo

备注/Memo:
收稿日期: 2016-11-23.基金项目：国家自然科学基金项目资助(81300984) 通讯作者：董海龙，教授，主要从事围术期心脑保护机制研究 Email:hldong6@hotmail.com 作者简介：郑旭，本科生 Email:3052012043@student.fmmu.edu.cn 共同第一作者：张梦诃，本科生 Email:3452013010@stndent.fmmu.edu.cn
更新日期/Last Update: 1900-01-01